Marc Kozin

Marc D.
Kozin is currently an Independent Director at UFP Technologies, Inc. since 2006, a Director at Helomics Corp., a Director at GreenLight Fund, Inc. since 2017, and an advisor at Healthcare Royalty Management LLC since 2013.
Former roles include Chairman at Vascular Biogenics Ltd. from 2021 to 2023, Director at Lynx Therapeutics, Inc. from 2002 to 2005, Independent Director at Dyax Corp.
from 2013 to 2016, Director at Medical Simulation Corp., Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021, Independent Director at Flex Pharma, Inc. from 2014 to 2019, Director at AdvizeX Technologies LLC, Director at CrunchTime!.
Information Systems, Inc. from 2002 to 2013, Independent Director at Endocyte, Inc. from 2013 to 2018, Director at Chimerix, Inc. from 2024 to 2025, Director at Brandwise, Inc. from 2002 to 2005, Director at Assurance Medical, Inc. from 1999 to 2001, Independent Director at OvaScience, Inc. from 2014 to 2018, Director at DukeEngage from 2011 to 2017, Independent Director at Frequency Therapeutics, Inc. from 2016 to 2018, Independent Director at Isleworth Healthcare Acquisition Corp.
in 2021, Governor at Tufts Medical Center, Inc., and President at LEK Consulting Pty Ltd. from 1997 to 2011.
Education includes an undergraduate degree from Duke University conferred in 1983 and an MBA from The Wharton School of the University of Pennsylvania conferred in 1987.